To continue using this website, please tell us a
little about yourself:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies on the website and how to delete cookies, see our Privacy and Cookie Policy.

I accept the FE Trustnet cookie policy

For more information Click here

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
 
Poll

Is the looming Brexit referendum affecting your investment decisions?

Yes, I’m making big changes
Yes, but only some tweaks
No, it will be a short-term blip

Vote

 
You are here: Factsheet

OMW Norway AXA Framlington Health

3 FE Trustnet

Underlying Fund

FE Crown Rating ( Underlying )

Fund Objective ( Underlying )

The aim of this Fund is to provide long-term capital growth.

Fund Manager ( Underlying )

Dani Saurymper

Domicile

Sector

Currency

Primary Asset Class

Fund Size

GBP 1.71m as at 31-Mar-2016

Downloads ( Underlying )

Unit Name

OMW Norway AXA Framlington Health

Inc/Acc

Accumulating 

Citicode

AS85

Initial Charge

n/a

Unit Currency

NOK 

ISIN

GB0005025621 

Annual Charge

n/a

Bid

NOK 44.00

Offer

NOK 44.00

Change (Offer)

-0.55 (-1.24%)
03-May-2016

Unit LaunchDate

21-Sep-2000

Performance Overview

Performance Charts

Cumulative Performance

  YTD 3m 6m 1y 3y 5y
Fund -2.98 6.22 1.59 -2.83 53.50 101.53
Sector 0.87 4.26 1.38 -1.31 11.83 19.34

Discrete Performance (%)

  2015 2014 2013 2012 2011
Fund 11.16 26.80 32.40 11.27 2.88
Sector 2.04 5.16 10.14 6.76 -5.30

Asset Allocation ( Underlying )

breakdown chart
  Asset Class % of Fund
North American Equities 71.73
Europe ex UK Equities 11.84
UK Equities 9.84
Japanese Equities 3.02
Global Emerging Market Equities 1.72
Money Market 1.28
Asia Pacific ex Japan Equities 0.57

Regional Breakdown ( Underlying )

breakdown chart
  Region % of Fund
North America 71.73
Europe Ex UK 11.84
UK 9.84
Japan 3.02
Emerging 1.72
Cash 1.28
Developed Asia Pacific ex Japan 0.57

Sector Breakdown ( Underlying )

breakdown chart
  Sector % of Fund
Pharmaceuticals 28.90
Biotechnology, Life Sciences Tools & Services 28.48
Health Care Technology, Managed Health Care, Health Care Services, Health Care Distributors, Health 21.20
Health Care Equipment 16.46
Health Care Facilities 2.05
Drug Retail 1.63
Cash 1.28

All prices in Pence Sterling (GBX) unless otherwise specified. Price performance figures are calculated on a bid price to bid price basis with net income (dividends) reinvested. Performance figures are shown in Sterling.

Data provided by FE. Care has been taken to ensure that the information is correct, but FE neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.